ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Biomoda, Inc. (OTCBB: BMOD) of Albuquerque, N.M., maker of early lung cancer detection testing and other cancer diagnostic technology, announced today that it signed an agreement with Cureline, Inc., a multi-national medical sample acquisition company, www.cureline.com to collect and provide sputum samples for Biomoda's ongoing validation and development work.
